1. Home
  2. FNWB vs CRDL Comparison

FNWB vs CRDL Comparison

Compare FNWB & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

N/A

Current Price

$9.04

Market Cap

87.5M

Sector

Finance

ML Signal

N/A

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

N/A

Current Price

$1.07

Market Cap

97.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNWB
CRDL
Founded
1923
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
97.3M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
FNWB
CRDL
Price
$9.04
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$13.50
$9.00
AVG Volume (30 Days)
24.2K
312.0K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
0.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$0.77
52 Week High
$10.98
$1.59

Technical Indicators

Market Signals
Indicator
FNWB
CRDL
Relative Strength Index (RSI) 28.63 55.89
Support Level $7.56 $0.95
Resistance Level $9.50 $1.10
Average True Range (ATR) 0.32 0.04
MACD -0.04 0.00
Stochastic Oscillator 12.55 69.97

Price Performance

Historical Comparison
FNWB
CRDL

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: